Epidemiology

Las Vegas Based Environ Safety LLC, Announces Its Global Partnership with RGF Environmental Group, to Provide High Quality Air with Advanced Oxidation Technologies to get the World Back to Work

Wednesday, June 3, 2020 - 9:20pm

RGF's Advanced Oxidation Technologies (AOT) are the most innovative technologies on the market, with more than four million successful applications currently being used worldwide.

Key Points: 
  • RGF's Advanced Oxidation Technologies (AOT) are the most innovative technologies on the market, with more than four million successful applications currently being used worldwide.
  • Lindsey and RGF have lofty goals as they collectively attack the biggest, most dangerous transmission of the virus: infected air.
  • RGF's patented Advanced Oxidation Technology (AOT) is the air, surface and food safety solution needed to bring not only Las Vegas but the entire Hospitality industry globally back to work.
  • *Disclaimer: RGF Advanced Oxidation Technologyhas not yet been tested specifically on SARS-CoV-2 and is not a medical device therefore no medical claims are made.

2020 Assessment of the Infectious Diseases Diagnostics Market and Impact of COVID-19 - Growing Number of COVID-19 Tests, Rise in Adoption of AI in Healthcare

Wednesday, June 3, 2020 - 4:45pm

The global infectious diseases diagnostics market reached US$24.32 billion in 2024, growing at a CAGR of 3.3% for the duration spanning 2020-2024.

Key Points: 
  • The global infectious diseases diagnostics market reached US$24.32 billion in 2024, growing at a CAGR of 3.3% for the duration spanning 2020-2024.
  • However, the market growth would be challenged by lack of skilled professionals, high cost of infectious diseases diagnostics and stringent government regulations.
  • The global infectious diseases diagnostics market is segmented into reagents, instruments and software.
  • The report provides a comprehensive analysis of the global infectious diseases diagnostics market.

New CPSC Report Finds Steady Rise in Fatal Child Drownings

Wednesday, June 3, 2020 - 3:15pm

Child drownings remain the leading cause of unintentional death among children ages 1 to 4 years old.

Key Points: 
  • Child drownings remain the leading cause of unintentional death among children ages 1 to 4 years old.
  • "Our latest report confirms that most child drownings take place at home during the summer months.
  • In addition to fatal drownings, CPSC's new data shows that there were an estimated 6,700 pool-or-spa-related, hospital emergency department-treated, nonfatal child drowning injuries each year for 2017 through 2019.
  • Note: CPSC's report addresses nonfatal drownings for the period 2017 through 2019 and fatal drownings for the period 2015 through 2017, reflecting a lag in the reporting of fatal drowning statistics.

New COVID-19 Forecasts Show Fragile Balance but Early Promise for Quiet Summer Across Many U.S. Counties

Wednesday, June 3, 2020 - 3:05pm

The model, which uses cell phone data to observe travel to non-essential businesses over time, continues to show reductions in social distancing across the country.

Key Points: 
  • The model, which uses cell phone data to observe travel to non-essential businesses over time, continues to show reductions in social distancing across the country.
  • Previous projections for some areas that had increased transmission over the last two weeksrepresented by counties in Alabama, Florida and Nevadastabilized this week.
  • The researchers will closely watch transmission risk for these communities and their feeder cities over the next two weeks.
  • A scientific review of the team's model and findings is available as a pre-print article ahead of peer review on medRxiv .

GenScript Files for Emergency Use Authorization of Rapid SARS-CoV-2 Neutralization Antibody Detection Kit

Wednesday, June 3, 2020 - 12:30pm

PISCATAWAY, N.J., June 3, 2020 /PRNewswire/ -- GenScript Biotech Corp ., the world's leading research reagent provider, announced today that the company has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) to market its cPass SARS-CoV-2 Neutralization Antibody Detection Kit.

Key Points: 
  • PISCATAWAY, N.J., June 3, 2020 /PRNewswire/ -- GenScript Biotech Corp ., the world's leading research reagent provider, announced today that the company has filed for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) to market its cPass SARS-CoV-2 Neutralization Antibody Detection Kit.
  • Traditional virus neutralization tests require live virus and cells and must be performed in a biosafety containment facility staffed by highly skilled personnel, with results often taking days.
  • GenScript was founded in New Jersey, US in 2002 and listed on the Hong Kong Stock Exchange in 2015.
  • GenScript has a number of intellectual property rights and technical secrets, including more than 100 patents and over 270 patent applications.

United States Night Vision Disturbances Market Epidemiology and Forecasts to 2028

Wednesday, June 3, 2020 - 11:15am

DUBLIN, June 3, 2020 /PRNewswire/ -- The "Night Vision Disturbances Market Insights, Epidemiology and Market Forecast - 2028" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 3, 2020 /PRNewswire/ -- The "Night Vision Disturbances Market Insights, Epidemiology and Market Forecast - 2028" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of NVDs in the United States.
  • The report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Night Vision Disturbances (NVD) from 2017 to 2028 in the United States.
  • The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Incident Cases of NVD in the United States, Incident cases of NVD by Type of Surgeries, Incidence of NVD Manifestations) scenario of Night Vision Disturbances (NVD)in the United States from 2017 - 2028.

Outlook on the Worldwide Infectious Disease Diagnostics Industry to 2027 - Key Drivers, Restraints, Opportunities & Threats - ResearchAndMarkets.com

Tuesday, June 2, 2020 - 4:18pm

The "Infectious Disease Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Infectious Disease Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Infectious Disease Diagnostics market accounted for $15.53 billion in 2018 and is expected to reach $28.79 billion by 2027 growing at a CAGR of 7.1% during the forecast period.
  • Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits.
  • Diagnosis for the causative organism of bacterial disease is always difficult since infections show symptoms like lethargy and fever.

Mosquito and Tick Populations are on the Rise – Learn How to Protect Against Vector Pests

Tuesday, June 2, 2020 - 1:30pm

As vector pests, mosquitoes and ticks are able to transmit pathogens to humans through their bites, making prevention especially important to help reduce transmission of dangerous and potentially deadly diseases.

Key Points: 
  • As vector pests, mosquitoes and ticks are able to transmit pathogens to humans through their bites, making prevention especially important to help reduce transmission of dangerous and potentially deadly diseases.
  • After a mild and wet winter across most of the country, mosquito and tick populations are expected to spike this summer, so its imperative the public is educated on how to protect themselves, said Cindy Mannes, vice president of public affairs for NPMA.
  • According to the CDC, mosquitoes kill more people than any other creature in the world.
  • For more information on mosquito and tick prevention, or to find a licensed pest professional, visit PestWorld.org .

Global HIV Therapeutics Market 2019-2023 | Growing Awareness About HIV to Boost Growth | Technavio

Monday, June 1, 2020 - 10:00pm

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR32179

Key Points: 
  • To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR32179
    Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources.
  • Our HIV therapeutics market report covers the following areas:
    This study identifies the advances in diagnostic testing for HIV as one of the prime reasons driving the HIV therapeutics market growth during the next few years.
  • Backed with competitive intelligence and benchmarking, our research reports on the HIV Therapeutics Market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Register for a free trial today and gain instant access to 17,000+ market research reports.

Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal

Monday, June 1, 2020 - 3:30pm

The Kazia data is presented in Abstract 2550 (NCT03522298).

Key Points: 
  • The Kazia data is presented in Abstract 2550 (NCT03522298).
  • The reported overall survival (OS) figure of 17.7 months represents a strong signal of clinical efficacy.
  • In April 2020, Kazia reported an interim analysis showing a PFS of 8.5 months in the overall study population (n=30).
  • This meeting has now been rescheduled to several virtual meetings, and Kazia will present a poster at the 'AACR Virtual Annual Meeting II' on 22-24 June 2020.